ARTICLE | Company News
Optimer sales and marketing update
July 25, 2011 7:00 AM UTC
Optimer launched Dificid fidaxomicin in the U.S. to treat Clostridium difficile-associated diarrhea (CDAD). As previously announced, the wholesale acquisition cost (WAC) for a 10-day course of the tw...